Second malignancies associated with doxorubicin.
Blatt
J
J
D004317:Doxorubicin / Q000009:adverse effects*; D006801:Humans; D016609:Neoplasms, Second Primary / Q000139:chemically induced* / Q000453:epidemiology; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000139:chemically induced* / Q000453:epidemiology; D012307:Risk Factors
D004317:Doxorubicin